Financials
- Market Capitalization 32.38 M
- Employee 25
- Founded 2000
- CEO Sandesh Seth
- Website www.actiniumpharma.com
- Headquarter Delaware, United States
- FIGI BBG000RQZ245
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
2.8
Relación precio/flujo de caja
0.88
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4402 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.39 USD | +1.46% | -18.71% | +24.11% | -65.93% | 33.38 M USD | ||
| 4403 | CNTX Context Therapeutics Inc. - Common Stock | 0.36 USD | 0.00% | -7.69% | -42.86% | -56.10% | 33.08 M USD | ||
| 4431 | BRNS Barinthus Biotherapeutics plc - American Depositary Shares | 0.76 USD | +5.56% | +5.56% | +33.33% | -39.68% | 31.05 M USD | ||
| 4432 | IGC IGC Pharma, Inc. Common Stock | 0.30 USD | 0.00% | -3.23% | +20.00% | +17.10% | 31.02 M USD |